发明授权
- 专利标题: Azaindazoles
-
申请号: US13696601申请日: 2011-05-05
-
公开(公告)号: US08637509B2公开(公告)日: 2014-01-28
- 发明人: Joelle Lorraine Burgess , Neil Johnson , Steven D. Knight , Louis LaFrance , William H. Miller , Kenneth Newlander , Stuart Romeril , Meagan B. Rouse , Xinrong Tian , Sharad Kumar Verma , Dominic Suarez
- 申请人: Joelle Lorraine Burgess , Neil Johnson , Steven D. Knight , Louis LaFrance , William H. Miller , Kenneth Newlander , Stuart Romeril , Meagan B. Rouse , Xinrong Tian , Sharad Kumar Verma , Dominic Suarez
- 申请人地址: US PA Philadelphia
- 专利权人: GlaxoSmithKline LLC
- 当前专利权人: GlaxoSmithKline LLC
- 当前专利权人地址: US PA Philadelphia
- 代理商 Duke M. Fitch; Kathryn A. Lutomski; John Lemanowicz
- 国际申请: PCT/US2011/035344 WO 20110505
- 国际公布: WO2012/005805 WO 20120112
- 主分类号: A61K31/444
- IPC分类号: A61K31/444 ; A61P35/00 ; A61K31/506 ; A61K31/5377 ; A61K31/513 ; C07D471/04 ; A61K31/4545
摘要:
Herein are disclosed azaindazoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
公开/授权文献
- US20130059849A1 AZAINDAZOLES 公开/授权日:2013-03-07